Hideo Kato

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 45

Top Topics

Systematic Review

Replacement Therapy

Extracorporeal Membrane Oxygenation

Respiratory Syncytial Virus

Top Venues

Antibiotics (Basel, Switzerland)

International journal of environmental research and public health

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Hideo Kato
Antibiotic therapy for bacterial pneumonia. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Hideo Kato
Antibiotic therapy for bacterial pneumonia. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Hideo Kato, Mao Hagihara, Shun-Ichi Hiramatsu, Hiroyuki Suematsu, Naoya Nishiyama, Nobuhiro Asai, Hiroshige Mikamo, Kazuko Yamamoto, Takuya Iwamoto
Evaluating the antimicrobial efficacy of ceftriaxone regimens: 1 g twice daily versus 2 g once daily in a murine model of Streptococcus pneumoniae pneumonia. JAC-antimicrobial resistance 6 (3) (2024)
Hideo Kato, Mao Hagihara, Shun-Ichi Hiramatsu, Hiroyuki Suematsu, Naoya Nishiyama, Nobuhiro Asai, Hiroshige Mikamo, Kazuko Yamamoto, Takuya Iwamoto
Evaluating the antimicrobial efficacy of ceftriaxone regimens: 1 g twice daily versus 2 g once daily in a murine model of Streptococcus pneumoniae pneumonia. JAC-antimicrobial resistance 6 (3) (2024)
Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Hideo Kato, Takumi Umemura, Mao Hagihara, Arifumi Shiota, Nobuhiro Asai, Yukihiro Hamada, Hiroshige Mikamo, Takuya Iwamoto
Development of a therapeutic drug-monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study. British journal of clinical pharmacology 90 (5) (2024)
Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Hideo Kato, Takumi Umemura, Mao Hagihara, Arifumi Shiota, Nobuhiro Asai, Yukihiro Hamada, Hiroshige Mikamo, Takuya Iwamoto
Development of a therapeutic drug-monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study. British journal of clinical pharmacology 90 (5) (2024)
Hideo Kato
Antibiotic therapy for bacterial pneumonia. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Kazuma Yagi, Nicholas W Lukacs, Gary B Huffnagle, Hideo Kato, Nobuhiro Asai
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses 16 (2) (2024)
Hideo Kato, Mao Hagihara, Shun-Ichi Hiramatsu, Hiroyuki Suematsu, Naoya Nishiyama, Nobuhiro Asai, Hiroshige Mikamo, Kazuko Yamamoto, Takuya Iwamoto
Evaluating the antimicrobial efficacy of ceftriaxone regimens: 1 g twice daily versus 2 g once daily in a murine model of Streptococcus pneumoniae pneumonia. JAC-antimicrobial resistance 6 (3) (2024)
Hideo Kato, Mao Hagihara, Shun-Ichi Hiramatsu, Hiroyuki Suematsu, Naoya Nishiyama, Nobuhiro Asai, Hiroshige Mikamo, Kazuko Yamamoto, Takuya Iwamoto
Evaluating the antimicrobial efficacy of ceftriaxone regimens: 1 g twice daily versus 2 g once daily in a murine model of Streptococcus pneumoniae pneumonia. JAC-antimicrobial resistance 6 (3) (2024)
Hideo Kato, Takumi Umemura, Mao Hagihara, Arifumi Shiota, Nobuhiro Asai, Yukihiro Hamada, Hiroshige Mikamo, Takuya Iwamoto
Development of a therapeutic drug-monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study. British journal of clinical pharmacology (2024)
Nobuhiro Asai, Yuichi Shibata, Akiko Nakamura, Hiroyuki Suematsu, Atsuko Yamada, Tomoko Ohno, Daisuke Sakanashi, Yuzuka Kawamoto, Narimi Miyazaki, Isao Koita, Hideo Kato, Mao Hagihara, Hirotoshi Ohta, Hiroshige Mikamo
Three Successfully Treated Cases of Lodderomyces elongisporus Fungemia: Case Reports and a Review of the Literature. Microorganisms 11 (4) (2023)
Jun Hirai, Nobuaki Mori, Daisuke Sakanashi, Wataru Ohashi, Yuichi Shibata, Nobuhiro Asai, Hideo Kato, Mao Hagihara, Hiroshige Mikamo
Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan. Viruses 15 (9) (2023)
Chihiro Shiraishi, Hideo Kato, Hiroshi Imai, Takuya Iwamoto
Impact of Extracorporeal Membrane Oxygenation in an Infant Treated with Vancomycin: A Case Report. International journal of environmental research and public health 20 (3) (2023)
Hideo Kato, Mao Hagihara, Nobuhiro Asai, Takumi Umemura, Jun Hirai, Nobuaki Mori, Yuka Yamagishi, Takuya Iwamoto, Hiroshige Mikamo
A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections. Mycoses (2023)
Chihiro Shiraishi, Hideo Kato, Hiroshi Imai, Takuya Iwamoto
Impact of Extracorporeal Membrane Oxygenation in an Infant Treated with Vancomycin: A Case Report. International journal of environmental research and public health 20 (3) (2023)
Chihiro Shiraishi, Hideo Kato, Hiroshi Imai, Takuya Iwamoto
Impact of Extracorporeal Membrane Oxygenation in an Infant Treated with Vancomycin: A Case Report. International journal of environmental research and public health 20 (3) (2023)
Nobuhiro Asai, Yuichi Shibata, Jun Hirai, Wataru Ohashi, Daisuke Sakanashi, Hideo Kato, Mao Hagihara, Hiroyuki Suematsu, Hiroshige Mikamo
A Gap of Patients with Infective Endocarditis between Clinical Trials and the Real World. Journal of clinical medicine 12 (4) (2023)
Nobuhiro Asai, Yuichi Shibata, Jun Hirai, Wataru Ohashi, Daisuke Sakanashi, Hideo Kato, Mao Hagihara, Hiroyuki Suematsu, Hiroshige Mikamo
A Gap of Patients with Infective Endocarditis between Clinical Trials and the Real World. Journal of clinical medicine 12 (4) (2023)
Nobuhiro Asai, Yuichi Shibata, Jun Hirai, Wataru Ohashi, Daisuke Sakanashi, Hideo Kato, Mao Hagihara, Hiroyuki Suematsu, Hiroshige Mikamo
A Gap of Patients with Infective Endocarditis between Clinical Trials and the Real World. Journal of clinical medicine 12 (4) (2023)
Nobuhiro Asai, Yuichi Shibata, Akiko Nakamura, Hiroyuki Suematsu, Atsuko Yamada, Tomoko Ohno, Daisuke Sakanashi, Yuzuka Kawamoto, Narimi Miyazaki, Isao Koita, Hideo Kato, Mao Hagihara, Hirotoshi Ohta, Hiroshige Mikamo
Three Successfully Treated Cases of Lodderomyces elongisporus Fungemia: Case Reports and a Review of the Literature. Microorganisms 11 (4) (2023)
Chihiro Shiraishi, Hideo Kato, Hiroshi Imai, Takuya Iwamoto
Impact of Extracorporeal Membrane Oxygenation in an Infant Treated with Vancomycin: A Case Report. International journal of environmental research and public health 20 (3) (2023)
Nobuhiro Asai, Yuichi Shibata, Akiko Nakamura, Hiroyuki Suematsu, Atsuko Yamada, Tomoko Ohno, Daisuke Sakanashi, Yuzuka Kawamoto, Narimi Miyazaki, Isao Koita, Hideo Kato, Mao Hagihara, Hirotoshi Ohta, Hiroshige Mikamo
Three Successfully Treated Cases of Lodderomyces elongisporus Fungemia: Case Reports and a Review of the Literature. Microorganisms 11 (4) (2023)
Nobuhiro Asai, Yuichi Shibata, Daisuke Sakanashi, Hideo Kato, Mao Hagihara, Yuka Yamagishi, Hiroyuki Suematsu, Hiroshige Mikamo
A Large Gap in Patients' Characteristics and Outcomes between the Real-World and Clinical Trial Settings in Community-Acquired Pneumonia and Healthcare-Associated Pneumonia. Journal of clinical medicine 11 (2) (2022)
Fumiya Ebihara, Yukihiro Hamada, Hideo Kato, Takumi Maruyama, Toshimi Kimura
Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan. International journal of environmental research and public health 19 (5) (2022)
Jun Hirai, Nobuhiro Asai, Mao Hagihara, Takaaki Kishino, Hideo Kato, Daisuke Sakanashi, Wataru Ohashi, Hiroshige Mikamo
Comparative Effectiveness of Ampicillin/Sulbactam versus Cefazolin as Targeted Therapy for Bacteremia Caused by Beta-Lactamase-Producing Methicillin-Sensitive Staphylococcus aureus : A Single-Center Retrospective Study. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Hideo Kato, Mao Hagihara, Nobuhiro Asai, Jun Hirai, Yuka Yamagishi, Takuya Iwamoto, Hiroshige Mikamo
Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Toshiki Murasaka, Hideo Kato, Hirofumi Sudo, Takuya Iwamoto
Usefulness of a Drug Information Resources Website (SAGASU-DI) Created Based on Inquiries to Clinical Pharmacists. Healthcare (Basel, Switzerland) 10 (8) (2022)
Hideo Kato, Mao Hagihara, Nobuhiro Asai, Takumi Umemura, Yuichi Shibata, Jun Hirai, Yuka Yamagishi, Takuya Iwamoto, Hiroshige Mikamo
Efficacy of Trimethoprim-Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Hideo Kato, Yukihiro Hamada
Amikacin Therapy in Japanese Pediatric Patients: Narrative Review. International journal of environmental research and public health 19 (4) (2022)
Hideo Kato, Mao Hagihara, Hiroko Matsuda, Takuya Iwamoto
Gentamicin Pharmacokinetics and Optimal Dosage in Infant Patients: A Case Report and Literature Review. International journal of environmental research and public health 19 (22) (2022)
Takumi Umemura, Yoshikazu Mutoh, Takahito Mizuno, Mao Hagihara, Hideo Kato, Tetsuya Yamada, Yoshiaki Ikeda, Hiroshige Mikamo, Toshihiko Ichihara
Safety Evaluation of Remdesivir for COVID-19 Patients with eGFR < 30 mL/min without Renal Replacement Therapy in a Japanese Single-Center Study. Healthcare (Basel, Switzerland) 10 (11) (2022)
Hideo Kato, Mao Hagihara, Yoshihiko Morikawa, Nobuhiro Asai, Hiroshige Mikamo, Takuya Iwamoto
Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia. Antibiotics (Basel, Switzerland) 11 (8) (2022)
Hideo Kato, Mao Hagihara, Mariko Kato, Yuka Yamagishi, Takumi Umemura, Nobuhiro Asai, Jun Hirai, Takuya Iwamoto, Hiroshige Mikamo
A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Hideo Kato, Mao Hagihara, Nobuhiro Asai, Jun Hirai, Yuka Yamagishi, Takuya Iwamoto, Hiroshige Mikamo
A Systematic Review and Meta-Analysis of Efficacy and Safety of Azithromycin Versus Moxifloxacin for the Initial Treatment of Mycoplasma genitalium Infection. Antibiotics (Basel, Switzerland) 11 (3) (2022)
Takumi Umemura, Hideo Kato, Mao Hagihara, Jun Hirai, Yuka Yamagishi, Hiroshige Mikamo
Efficacy of Combination Therapies for the Treatment of Multi-Drug Resistant Gram-Negative Bacterial Infections Based on Meta-Analyses. Antibiotics (Basel, Switzerland) 11 (4) (2022)
Hideo Kato, Suzanne L Parker, Jason Alexander Roberts, Mao Hagihara, Nobuhiro Asai, Yuka Yamagishi, David L Paterson, Hiroshige Mikamo
Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients. Antibiotics (Basel, Switzerland) 10 (2) (2021)
Mao Hagihara, Hideo Kato, Toshie Sugano, Hayato Okade, Nobuo Sato, Yuichi Shibata, Daisuke Sakanashi, Jun Hirai, Nobuhiro Asai, Hiroyuki Suematsu, Yuka Yamagishi, Hiroshige Mikamo
In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing Enterobacter cloacae and Klebsiella pneumoniae in Murine Pneumonia Model. Antibiotics (Basel, Switzerland) 10 (10) (2021)